1. 于金明 中国 山东第一医科大学 中国工程院院士 Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Grow..
2. 赫捷 中国 中国医学科学院 中国科学院院士 Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show di..
3. Satoshi,Morita 日本 Kyoto University Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TR..
4. Yoshino, Takayuki 日本 National Cancer Center Hospital East Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TR..
5. Byoung Chul,Cho 韩国 Yonsei University Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic ..
6. Myung-Ju,Ahn 韩国 Sungkyunkwan University Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic ..
7. Dong-Wan,Kim 韩国 Seoul National University Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic ..
8. Douglas,Kondziolka 美国 New York University EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptom..
9. Xiang H. -F,Zhang 美国 Baylor College of Medicine Associations amongst genes, molecules, cells, and organs in breast cancer metastasis
10. Nobuyuki,Yamamoto 日本 Wakayama Medical University Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors ..
11. Yuichiro,Ohe 日本 National Cancer Center Hospital Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors ..
12. 施金元 中国 国立台湾大学 Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epider..
13. Byoung Chul,Cho 韩国 Yonsei University A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated ..
14. Caraglia, Michele 意大利 University of Campania Luigi Vanvitelli Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlate..
15. Ferdinando,De Vita 意大利 University of Naples 2 Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlate..
16. Fortunato,Ciardiello 意大利 Second University of Naples Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlate..
17. Michael,Detmar 瑞士 ETH Zurich lymphatic vessels in cancer
18. Makoto,Maemondo 日本 Iwate Medical University Treatment with immune checkpoint inhibitors after EGFR-TKIs in EGFR-mutated lung cancer
19. Alexander N,Orekhov 俄罗斯 Institute General PATHOL & PATHOPHYSIOL Role of the mtDNA Mutations and Mitophagy in Inflammaging
20. Andrea,Ardizzoni 意大利 University of Bologna Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations